Ataciguat

DB12805InvestigationalSmall molecule

Ataciguat has been investigated for the basic science of Aortic Valve Stenosis.

Chemical structure of Ataciguat
Formula / weight
C21H19Cl2N3O6S3 · 576.48 g/mol (avg)

Resolves to

Compound
UNIIQP166M390QCAS254877-67-3ChEMBLCHEMBL2107729PubChem213037
Structure
InChIKeyPQHLRGARXNPFCF-UHFFFAOYSA-NSMILESClC1=CC=C(S1)S(=O)(=O)NC1=C(C=C(Cl)C=C1)C(=O)NC1=CC=C(C=C1)S(=O)(=O)N1CCOCC1
Targets
P16066NPR1

What you can answer from here — as of July 08, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Ataciguat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In